Conditions for the use of protective vaccination in the control and eradication of foot-and-mouth disease in application of Article 13(3) of Directive 85/511/EEC
>TABLE>
ANNEX II
Vaccination zone:
Administrative areas in the counties of Cumbria and Devon in Great Britain.
ANNEX III
MEASURES APPLICABLE IN THE VACCINATION ZONE
1. The United Kingdom shall ensure that the following measures are applied in the vaccination zone during the period from the beginning of the vaccination until at least 30 days have elapsed following the completion of the vaccination:
(a) Movement of live vaccinated bovine animals is prohibited within and out of the vaccination zone.
Derogating from the prohibition above and after clinical inspection of the animals in question and of the herds of origin or dispatch, the competent authorities may authorise the direct transport of live bovine animals species for immediate slaughter in a slaughterhouse designated by the competent authority and situated within the vaccination zone or in exceptional circumstances to be authorised on a case by case basis by the competent authorities preferably close to that zone.
(b) Fresh meat produced from vaccinated animals slaughtered during the period referred to in this paragraph shall bear the stamp provided for in Article 5a of Directive 72/461/EEC, shall be stored and transported separately from meat not bearing the said stamp, and shall subsequently be transported in sealed containers to an establishment designated by the competent authorities for treatment in accordance with Annex IV.
(c) Milk and milk products produced from vaccinated animals during the period referred to in this paragraph may be placed on the market within or out of the vaccination zone, provided that at least one of the treatments referred to in Annexes VI-A and VI-B has been applied in an establishment located in the vaccination zone or, in exceptional circumstances to be authorised on a case by case basis by the competent authorities outside that zone. This treatment shall be certified by the competent veterinary authorities.
(d) The collection of semen for artificial insemination from male bovine animals kept in centres situated within the vaccination zone shall be suspended.
Derogating from the prohibition above, the competent authorities may authorise the collection of semen from male bovine animals for the production of frozen semen to be used within the vaccination zone at semen collection centres within the vaccination zone, if it is ensured that the semen collected during that period is stored separately for at least 30 days and is dispatched only after the following measures have been taken:
the donor males have been vaccinated following a negative test for antibodies against foot-and-mouth disease virus undertaken prior to vaccination, and
a negative result has been achieved in all susceptible animals present at the time on the semen collection centre, in a virus isolation test or in an approved test for antibody against non-structural proteins carried out at end of the quarantine period for the semen.
(e) Collection of ova and embryos from donor female bovines shall be prohibited.
2. The United Kingdom shall ensure that the following measures are applied in the vaccination zone after the completion of the measures laid down in paragraph 1 and until the restrictions on the vaccination zone are lifted:
(a) Intra-Community trade in bovine animals seropositive against foot-and-mouth disease is prohibited.
(b) Intra-Community trade in semen, ova and embryos of bovine animals vaccinated against foot-and-mouth disease is prohibited.
(c) Collection of ova shall be prohibited.
(d) Movement of bovine animals may only take place under the following conditions:
Movement out of the vaccination zone of non-vaccinated bovine animals other than those referred to in point (3) below may be authorised not earlier than 3 months after completion of all vaccination and in accordance with Directive 85/511/EEC.
Derogating from the provisions in the first subparagraph above, the United Kingdom may authorise the transport of non-vaccinated bovine animals to a slaughterhouse outside the vaccination zone for immediate slaughter, provided that the meat shall be subjected to the treatment in Annex V.
Movement out of the vaccination zone of vaccinated bovine animals shall be prohibited, unless 12 months have elapsed after the completion of the measures referred to in paragraph 1 and not earlier than 12 months after the last outbreak in the zone, whichever is the latest.
Derogating from the provisions in the first subparagraph, the United Kingdom may authorise the transport of vaccinated bovine animals to a designated slaughterhouse outside the vaccination zone for direct slaughter, provided that the meat shall be subjected to the treatment in Annex V.
Non-vaccinated offspring of vaccinated dams, shall be prohibited from leaving the holding of origin unless being transported to:
either a slaughterhouse for immediate slaughter, the meat being subject to the treatment in Annex V, or
to another holding within the vaccination zone, or
any holding after obtaining a negative result in a serological test for the detection of antibody against the foot-and-mouth disease virus.
(e) The restrictions applied to fresh meat produced from vaccinated animals of susceptible species as laid down in Annex V, and to meat products as laid down in Annex VI, shall continue to apply until the restrictions on movements of vaccinated animals of susceptible species have been lifted in accordance with Article 16 of Directive 85/511/EEC, and in any case not earlier than 12 months after the completion of vaccination and 12 months after the last outbreak in the vaccination zone whichever is the latest.
(f) The restrictions applied to fresh milk produced from vaccinated animals of susceptible species and to milk products produced from such milk as laid down in Annexes VI-A and VI-B shall continue to apply until the restrictions on movements of vaccinated animals of susceptible species have been lifted in accordance with Article 16 of Directive 85/511/EEC, and in any case not earlier than 12 months after the completion of vaccination and 12 months after the last outbreak in the vaccination zone whichever is the latest.
ANNEX IV
TREATMENT OF MEAT TO ENSURE DESTRUCTION OF FOOT-AND-MOUTH DISEASE VIRUS
>TABLE>
ANNEX V
TREATMENT OF FRESH MEAT
1. De-boned fresh meat:
Meat as described in Article 2(a) of Council Directive 64/433/EEC together with diaphragms but excluding offal, from which the bone and the main accessible lymphatic glands have been removed.
2. Trimmed offal:
- heart from which lymphatic glands, connective tissue and adhering fat have been completely removed,
- liver from which lymphatic glands, adhering connective tissue and fat have been completely removed,
- whole masseter muscles, incised in accordance with paragraph 41 (A)(a) of Chapter VIII of Annex I to Directive 64/433/EEC, from which lymphatic glands, connective tissue and adhering fat have been completely removed,
- tongues with epithelium and without bone, cartilage and tonsils,
- lungs from which the trachea and main bronchi and the mediastinal and bronchial lymphatic glands have been removed,
- other offal without bone or cartilage from which lymphatic glands, connective tissue, adhering fat and mucous membrane have been completely removed.
3. Maturation
- maturation of carcasses at a temperature of more than + 2 °C for at least 24 hours,
- pH value in the middle of Longissimus dorsi muscle recorded as less than 6.0.
4. Effective measures must be applied to avoid cross contamination.
ANNEX VI-A
TREATMENT OF MILK TO ENSURE DESTRUCTION OF FOOT-AND-MOUTH VIRUS IN MILK FOR HUMAN CONSUMPTION
Treatment of milk must be carried out in accordance with paragraph 1 below and in any case necessary precautions must be taken to avoid contact of the milk or milk products with any potential source of foot-and-mouth virus after processing.
1. Milk for human consumption must be subject to at least one of the following treatments:
1.1. sterilisation at a level of at least F03,
1.2. single UHT(1) treatment,
1.3. double HTST(2) treatment of milk with a pH above 7,0,
1.4. single HTST treatment of milk with a pH less than 7,0,
1.5. single HTST combined with another physical treatment by:
1.5.1. either a second heat treatment resulting in a negative reaction to the peroxidase test,
1.5.2. or lowering the pH < 6 for at least one hour,
1.5.3. or additional heating to 72 °C or more, combined with desiccation.
2. Milk based products must be produced from milk after the treatment referred to in paragraph 1.
(1) UHT = Ultra High Temperature treatment at 130 °C for 2-3 sec.
(2) HTST = High Temperature Short Time pasteurisation at 72 °C for 15-17 sec or equivalent pasteurisation effect achieving a negative reaction to a phosphatase test.
ANNEX VI-B
TREATMENT OF MILK TO ENSURE DESTRUCTION OF FOOT-AND-MOUTH VIRUS IN MILK NOT INTENDED FOR HUMAN CONSUMPTION AND IN MILK FOR ANIMAL CONSUMPTION
Treatment of milk and milk-based products must be carried out in accordance with paragraphs 1 to 3 below depending on the intended use of the milk or milk-based products, and in any case necessary precautions must be taken to avoid contact of the milk or milk based products with any potential source of foot-and-mouth virus after processing.
1. Milk not intended for human consumption and milk intended for animal consumption must be subject to at least one of the following treatments:
1.1. sterilisation at a level of at least F03,
1.2. single UHT(1) combined with another physical treatment referred to in either paragraph 1.4.1. or 1.4.2.
1.3. double HTST(2),
1.4. single HTST combined with another physical treatment by
1.4.1. either lowering the pH < 6 for at least one hour,
1.4.2. or additional heating to 72 °C or more, combined with desiccation.
2. Milk-based products not intended for human consumption must be produced from milk after the treatments referred to in paragraph 1.
3. Milk-based products intended for animal consumption must be produced from milk after one of the treatments referred to in paragraph 1.1., 1.2. and 1.4.
4. Whey to be fed to pigs and produced from milk treated as described in paragraph 1 must be collected at least 16 hours after milk clotting and its pH must be recorded as < 6,0 before transport to pig holdings.
(1) UHT = Ultra High Temperature treatment at 130 °C for 2-3 sec.
(2) HTST = High Temperature Short Time pasteurisation at 72 °C for 15-17 sec or equivalent pasteurisation effect achieving a negative reaction to a phosphatase test.
